Jove
Visualize
Contact Us

Related Experiment Videos

Relation between endothelial dysfunction and the acute coronary syndrome: implications for therapy.

S Kinlay1, P Ganz

  • 1Harvard Medical School and the Cardiac Catheterization Laboratory, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.

The American Journal of Cardiology
|November 18, 2000
PubMed
Summary

Statin therapy improves endothelial dysfunction, a marker of early cardiovascular disease, by boosting nitric oxide production. This enhances blood flow and stabilizes plaques, supporting early treatment initiation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of short-term increases in personal and ambient pollutant concentrations on pulmonary and cardiovascular function: A panel study analysis of the Multicenter Ozone Study in oldEr subjects (MOSES 2).

Environmental research·2021
Same author

Multicenter Ozone Study in oldEr Subjects (MOSES): Part 2. Effects of Personal and Ambient Concentrations of Ozone and Other Pollutants on Cardiovascular and Pulmonary Function.

Research report (Health Effects Institute)·2020
Same author

Multicenter Ozone Study in oldEr Subjects (MOSES): Part 1. Effects of Exposure to Low Concentrations of Ozone on Respiratory and Cardiovascular Outcomes.

Research report (Health Effects Institute)·2020
Same author

Early statin therapy in acute coronary syndromes.

Minerva cardioangiologica·2003
Same author

Rheolytic thrombectomy for in-stent thrombosis: creating a diagnostic window.

Journal of interventional cardiology·2002
Same author

Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection.

Circulation·2001
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Pharmacology

Background:

  • Endothelial dysfunction is an early indicator of atherosclerosis and cardiovascular disease risk.
  • It precedes visible plaque formation, highlighting its role in disease initiation.
  • Dysfunctional endothelium promotes arterial inflammation and leukocyte recruitment.

Purpose of the Study:

  • To evaluate the impact of statin therapy on endothelial function in atherosclerosis.
  • To explore the mechanisms by which statins improve endothelial function.
  • To determine the clinical benefits of improved endothelial function due to statin use.

Main Methods:

  • Analysis of studies investigating statin therapy effects on endothelial function.
  • Assessment of changes in nitric oxide production and vasodilation.

Related Experiment Videos

  • Evaluation of clinical outcomes such as myocardial perfusion and angina.

    • Main Results:

    • Statin therapy improves endothelial function by enhancing nitric oxide (NO) production.
    • Benefits are observed through both lipid-lowering and non-lipid-lowering mechanisms.
    • Functional improvements include enhanced myocardial perfusion and reduced angina.

    Conclusions:

    • Statin therapy offers early functional cardiovascular benefits by improving endothelial function.
    • Prompt initiation of statin therapy is supported by these early beneficial effects.
    • Improved endothelial function contributes to plaque stabilization and reduced inflammation.